Board Meeting26 Mar 2026, 02:59 pm
Bafna Pharmaceuticals Ltd Announces Closure of Trading Window Until 48 Hours After Q4 and FY26 Results
AI Summary
Bafna Pharmaceuticals Ltd has announced the closure of its trading window for designated persons and their immediate relatives, in accordance with SEBI regulations and the company's Code of Conduct for Prevention of Insider Trading. The trading window will remain closed from April 01, 2026 till 48 hours after the declaration of Audited Financial Results for the Quarter and Financial Year ending March 31, 2026. This move is aimed at preventing insider trading during the sensitive period surrounding the release of financial results.
Key Highlights
- Bafna Pharmaceuticals Ltd announces closure of trading window for designated persons and their immediate relatives.
- The closure is in accordance with SEBI regulations and the company's Code of Conduct for Prevention of Insider Trading.
- The trading window will remain closed from April 01, 2026 till 48 hours after the declaration of Q4 and FY26 results.
- This move is aimed at preventing insider trading during the sensitive period surrounding the release of financial results.
- Designated persons and their immediate relatives have been intimated not to trade in the company’s securities during the aforesaid period.
Price Impact
More from BAFNAPHARM